RGUHS Nat. J. Pub. Heal. Sci Vol: 14 Issue: 1 eISSN: pISSN
Vora A*, Hajare A**, Krishnaprasad K**, Bhargava A**
*Asst Hon Chest Physician, Dept of Chest & TB, Dr. RN Cooper Municipal Gen Hospital, Mumbai **Medical Services, Glenmark
Abstract
Community acquired pneumonia (CAP) is a major cause of adult mortality in Asia. Empirical use of antibiotics depends upon the pathogens which are commonly responsible. Evolution of resistant pathogens in CAP has added to the burden of treating physicians. Microbiological culture and antibiotic sensitivity testing are helpful for the treatment of such respiratory tract infections. Klebsiella pneumonia though uncommon pathogen of CAP has been reported in many cases. Cefuroxime a second generation cephalosporin has found its utility in the treatment of respiratory tract infections. Providing symptomatic relief to the patient with the use of analgesics, antipyretics & cough preparations is also an essential part of the management.
Keywords
Downloads
-
1FullTextPDF
Article
none
Supporting Files
References
none